Andrew Kuykendall, MD; Marina Kremyanskaya MD, PhD; Lucia Masarova, MD; Douglas A. Tremblay, MD

Community Practice Connections™: How We Do It: Application of State-of-the-Art MF and PV Care Today… With An Eye Toward How New Evidence and Combinations Will be Leveraged Tomorrow

Corey Cutler, MD, MPH, FRCPC; Sergio Giralt, MD, FACP, FASTCT; Catherine Lee, MD; Doris M. Ponce, MD

Medical Crossfire®: How Do We Apply the Latest Evidence on Novel Therapies to Prevent and Treat GVHD?

Jacob Sands, MD; Zev A. Wainberg, MD; Aditya Bardia, MD, MPH

Medical Crossfire®: Antibody-Drug Conjugates Coming to Your Oncology Practice Tomorrow

Verena Staedtke, MD, PhD; Matthias A. Karajannis, MD, MS; Shannon Langmead, RN, MSN, CRNP, CNRN

Medical Crossfire®: What Strategies Can the Care Team Implement to Optimize the Management of Pediatric Patients with NF1?

Joyce O’Shaughnessy, MD; Aditya Bardia, MD, MPH; Dejan Juric, MD; Lisa Newman, MD, MPH, FACS, FASCO; Priya Rastogi, MD

Medical Crossfire®: Clinical Decision-Making Under New Paradigms for HR+/HER2- Breast Cancer

Loretta J. Nastoupil, MD; Ian W. Flinn, MD, PhD; Caron A. Jacobson, MD, MMSc; Jessica Okosun, MB BChir, PhD 

Follicular Lymphoma Workshop: Forging Patient-Centric Plans with Targeted Therapies Across Lines of Care

Gregory J. Riely, MD, PhD; Erica Stumpf, MSN, NP-BC

Show Me Your Care Plan™: Monitoring and Managing Patients With EGFR Exon20 Insertion+ NSCLC

Oncology Town Hall™: Primary Investigators Present Key Abstracts in Genitourinary Malignancies from Paris

Erika P. Hamilton, MD; Benjamin P. Levy, MD

Burst CME™ - Part II – Advent of HER3 Targeted Approaches and Rationale in NSCLC Care

Burst CME™ - Part I – Overview of Pathophysiology, Diagnosis, and Management of HER3 Expressing Cancers

Burst CME™ - Part III – Advent of HER3 Targeted Approaches and Rationale in Breast Cancer Care

How We Do It: Application of State-of-the-Art MF and PV Care Today… With An Eye Toward How New Evidence and Combinations Will be Leveraged Tomorrow

Medical Crossfire®: How Do We Apply the Latest Evidence on Novel Therapies to Prevent and Treat GvHD?

Nikhil C. Munshi, MD; Faith E. Davies, MD; Brandon Blue, MD; Shaji Kumar, MD

Clinical Interchange™: Improving Outcomes and Overcoming Barriers to Equitable Care in African American Patients With Multiple Myeloma 

Oncology Town Hall™: Primary Investigators Present Key Abstracts in Gastrointestinal Malignancies from Paris

Tanios S. Bekaii-Saab, MD; Kristen Ciombor, MD, MSCI; Yelena Y. Janjigian, MD; Milind Javle, MD; Eileen M. O’Reilly, MD

Community Practice Connections™: 19th Annual Meeting of the International Society of Gastrointestinal Oncology®

Andre H. Goy, MD; Charu Aggarwal, MD, MPH; C. Ola Landgren, MD, PhD; Elias Obeid, MD, MPH; Susan F. Slovin, MD, PhD; Benjamin A. Weinberg, MD

Community Practice Connections™: 4th annual Precision Medicine Symposium: An Illustrated Tumor Board

Onye J. Ononogbu, PharmD, BCOP; Margaret Quinn Rosenzweig, PhD, FNP-BC, AOCNP, FAAN; Ana Maria Lopez, MD, MPH, MACP, FRCP; Susan Fugett, MSW, LISW-S, OSW-C, CSW-G

  Clinical Conversations With the Cancer Care Team: Discussing the Impact of Social Inequities on Treatment Outcomes in Triple-Negative Breast Cancer

Robert Z. Orlowski, MD, PhD; Elisabet E. Manasanch, MD, MHSc; Jing Christine Ye, MD, MSc

Clinical Vignettes: Charting The Changing Landscape in Multiple Myeloma from Frontline to Relapsed/Refractory Disease

Charu Aggarwal, MD, MPH; David R. Gandara, MD; Lynette M. Sholl, MD; Ignacio I. Wistuba, MD

Virtual Testing Board: Digging Deeper on Your Testing Reports to Elevate Patient Outcomes in Advanced Non–Small Cell Lung Cancer

Grace Cherry, MSN, RN, NP; Beth Sandy, MSN, CRNP; Laura S. Wood, MSN, RN, OCN; Patricia Mangan, MSN, RN, CRNP, APRN-BC; Kimberly Podsada, MSN, NP-C; Rowena “Moe” Schwartz, PharmD, BCOP,
FHOPA



Community Practice Connections™: 6th Annual School of Nursing Oncology

Burst CME: Regulatory Approval Pathways for Influenza Vaccines

John Mascarenhas, MD; Heinz Gisslinger, MD; Kathryn Johnson, DNP, MSc, FNP-BC; Naveen Pemmaraju, MD


4th Annual Virtual Tumor Board®: Diagnosis and Management of Polycythemia Vera and Myelofibrosis

Shakeel Modak, MD, MRCP; Araz Marachelian, MD, MS

Advances In™ Pediatric Neuroblastoma: Exploring Current and Emerging Therapeutic Approaches for Relapsed/Refractory Disease and CNS Metastases

Abbey Kaler, MS, APRN, FNP-C; Kelly Leonard, MSN, APRN, FNP-BC

Cases and Conversations™: Nursing Considerations for the Management of ER+ Breast Cancer

Charting The Changing Landscape in Multiple Myeloma from Frontline to Relapsed/Refractory Disease

Arshad M. Khanani MD, MA; Jennifer I. Lim MD, FARVO, FASRS

(COPE Credit) Expert Illustrations & Commentaries™: Visualizing the Angiopoetin-Tie2 Pathway as a Target in Retinal and Choroidal Vascular Diseases

(CME/CNE Credit) Expert Illustrations & Commentaries™: Visualizing the Angiopoetin-Tie2 Pathway as a Target in Retinal and Choroidal Vascular Diseases

Pasi A. Jänne, MD, PhD; Jason Chang, MD; Gregory Riely, MD, PhD; Beth Sandy, MSN, CRNP, OCN 

Clinical Vignettes®: Multidisciplinary Discussions on the Application of Novel EGFR Exon 20 Targeted Regimens for NSCLC Management

Naval G. Daver, MD ; Guillermo Garcia-Manero, MD ; Uma Borate, MD, MS ; Jacqueline S. Garcia, MD 

Clinical Vignettes: Reshaping Higher-Risk MDS Patient-Centered Care with Emergence of Novel Evidence and Clinical Trials

Laura S. Wood RN, MSN, OCN; Kathleen D. Burns, MSN, AGACNP-BC, OCN; Michael E Seabright Jr, PharmD, BCOP

Show Me Your Care Plan! Developing Multidisciplinary Strategies to Optimize the First-Line Care of Patients with mRCC

Elizabeth (Ebbie) Stewart, MD; Hugh Taylor, MD; Homa K. Ahmadzia, MD, MPH; Alyssa Brown, MD; Isabel C. Green, MD; Cynthia Gyamfi-Bannerman, MD, MS; Michael J. Joyner, MD; Amanda N. Kallen, MD, FACOG; Beth Y. Karlan, MD; Heather S. Lipkind, MD, MS; Judette Louis, MD, MPH; JoAnn V. Pinkerton, MD, FACOG, NCMP; Nancy Ringel, MD, MS; Nanette Santoro, MD; Moeun Son, MD, MSCI, FACOG

3rd Annual International Congress on the Future of Women’s Health™

Edgardo S. Santos, MD, FACP; Julia Rotow, MD

Advances In™ NSCLC: Exploring CEACAM5 As A New Therapeutic Target

Kenneth C. Anderson, MD; Elias Jabbour, MD; Gilles A. Salles, MD, PhD

Community Practice Connections™: 6th Annual Live Medical Crossfire®: Hematologic Malignancies 

Megan Hinkley, PharmD, BCOP; Meg Taylor, PharmD, CPP

Updates in Therapeutic Strategies for Metastatic Renal Cell Carcinoma: A Multidisciplinary Approach to Optimal Management of Adverse Effects, featuring Counseling Vignettes

Emanuele Zucca, MD; Massimo Federico, MD; Pier Luigi Zinzani, MD, PhD 

Medical Crossfire®: How the Experts Manage Advanced HL and PTCL in the Real World from Frontline to R/R Treatment Settings

Cancer Summaries and Commentaries™: Investigating Key Updates for the Treatment and Management of AML and MDS

Charu Aggarwal, MD, MPH; Dara Aisner, MD, PhD; Balazs Halmos, MD, MS; Julia Kathleen Rotow, MD; David R. Gandara, MD

Community Practice Connections™: Top 10 Oncogenic Markers in NSCLC for 2022: Evolution of Tumor Testing Technologies, Novel Treatments, and Trials!

Jessica Michaud Davis, PharmD, BCOP, CPP; Robert L. Ferris, MD, PhD; Kristi K Orbaugh, MSN, NP, AOCNP

Optimizing Immune Checkpoint Inhibitors in Early-Stage Cancer Treatment Through Multidisciplinary Collaboration

Benjamin P. Levy, MD; David R. Gandara, MD; Aparna R. Parikh, MD, MS; Heather A. Parsons, MD, MPH

Community Practice Connections™:  Analyzing the Evolving Role of Liquid Biopsies Across Cancer Care

Clinical Vignettes™: Testing and Treatment Strategies in Cholangiocarcinoma

Bradley J. Monk, MD, FACS, FACOG; Lucy Gilbert, MD, MSc, FRCOG; Bhavana Pothuri, MD, MS; Matthew A. Powell, MD

Medical Crossfire®: How Are We Personalizing Integration of ICIs and Targeted Therapies to Optimize Outcomes in Endometrial Cancer?

Charu Aggarwal, MD, MPH; Dara Aisner MD, PhD; D. Ross Camidge, MD, PhD; Balazs Halmos, MD, MS; Julia Kathleen Rotow, MD

Top 10 Oncogenic Markers in NSCLC for 2022: Evolution of Tumor Testing Technologies, Novel Treatments, and Trials!

Krishna Komanduri, MD; Juan Ramirez, APRN-BC; Charalambos Andreadis, MD; Laura J. Zitella, NP, MSN

Community Practice Connections™: Optimally and Safely Integrating Novel Therapies Across the DLBCL Care Spectrum

Michael A. Choti, MD; John L. Marshall, MD; Christopher Lieu, MD; Manish A. Shah, MD

Community Practice Connections™: 7th Annual School of Gastrointestinal Oncology®

Patrick I. Borgen, MD; Sara A. Hurvitz, MD, FACP; Hope S. Rugo, MD, FASCO; Debu Tripathy, MD

39th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™

Joyce O’Shaughnessy, MD; Heather L. McArthur, MD, MPH; Hatem Soliman, MD

Community Practice Connections™: Integrating New Treatment Options into the Management of Triple Negative Breast Cancer

Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA; I. Brian Greenwell, MD; Mary Nauffal, PharmD, MS, BCOP; Jennifer K. Elder, RN, MSN, BMTCN

Clinical Conversations with the Cancer Care Team: Optimizing the Care of Patients on CAR T-Cell Therapy Through Multidisciplinary Collaboration and Patient Insights

Angela Fleischman, MD, PhD; Jill Brennan-Cook, DNP, RN-BC, CNE; Natasha Johnson, MSN, APRN, AOCNP; Sandra Kurtin, PhD, ANP-C, AOCN


Cases and Conversations™ With the Oncology Nursing Team: Making Sense of How We Treat MPNs Today and How Novel Strategies Will Shape Patient Care Tomorrow

Jared Weiss, MD; Michael Pulley, MD, PhD; Beth Sandy, MSN, CRNP

Virtual Tumor Board®: Multidisciplinary Approaches to Treating Cancer-related LEMS

Debu Tripathy, MD; Aditya Bardia, MD, MPH; Claudine Isaacs, MD; Tiffany A. Traina, MD

Community Practice Connections ™: Aligning the Data With Strategy to Improve Breast Cancer Outcomes with PARP, HER2/3, and TROP2 Targeted Regimens

Oncology On-Call®: Advancing Care in SCLC with Novel Therapies

Omid Hamid, MD; Jeffrey S. Weber, MD, PhD; Rodabe N. Amaria, MD; Ragini Kudchadkar, MD; Sapna Patel, MD

Community Practice Connections™: 18th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

Maria Dimou, MD, PhD; Matthew S. Davids, MD, MMSc; Karthik Ramasamy, MBBS, FRCP, FRCPath, PhD; Joshua Richter, MD

Medical Crossfire®: How the Experts Differentiate Secondary Immunodeficiencies to Improve Patient Outcomes Across Hematologic Cancer Care

Aditya Bardia, MD, MPH; Joyce O’Shaughnessy, MD; Mothaffar F. Rimawi, MD

Medical Crossfire®: Bridging Current Practices and New Therapeutic Developments in ER-Positive Breast Cancer

Bradley J. Monk, MD, FACS, FACOG; Robert L. Coleman, MD, FACOG, FACS; Domenica Lorusso, MD, PhD; Ursula A. Matulonis, MD

Medical Crossfire®: How Are We Integrating Immune Checkpoint Inhibitors and Targeted Therapies to Personalize Therapy in Endometrial Cancer?

Nicolas Palaskas, MD, FACC; Daniel Addison, MD; Eric H. Yang, MD, FACC, FASE; Lili Zhang, MD, FACC

Provider and Caregiver Connection Live: Aligning Oncology and Cardiology Care to Identify and Manage ICI-Related Myocarditis

Joyce O’Shaughnessy MD; Heather L McArthur MD,  MPH; Hatem Soliman MD


Integrating New Treatment Options into the Management of Triple Negative Breast Cancer: An Expert Tumor Board Discussion

Hope S. Rugo, MD, FASCO; Sara M. Tolaney, MD, MPH

Clinical Vignette Series: Navigating the Evolving Treatment Landscape for HR-Positive Breast Cancer

Robert Ferris, MD, PhD, Yelena Y. Janjigian, MD, John Timmerman, MD, Jeffrey Weber, MD, PhD

Community Practice Connections™: 6th Annual International Congress on Immunotherapies in Cancer™: Focus on Practice-Changing Application

Ajai Chari, MD; Alexander E. Drilon, MD; Daniel J. George, MD; Benjamin P. Levy, MD; Kathleen Moore, MD; Sarbajit Mukherjee, MD, MS; Christine M. Parseghian, MD; Gilles A. Salles, MD, PhD; Tiffany A. Traina, MD

Clinical Vignette Series - 39th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®

Howard A. Liebman, MD, MA; Catherine M. Broome, MD

Continuing Education